Skip to main content

Table 1 Characteristics of persons diagnosed with AIDS in San Francisco, 1996–2006, by housing status at diagnosis (N = 6558)

From: Impact of housing on the survival of persons with AIDS

Characteristics

Homeless

Non-Homeless

 
 

(N = 641)

 

(N = 5917)

  
 

N

%

N

%

P value*

Gender

    

<0.0001

   Male

497

77.54

5363

90.64

 

   Female

94

14.66

399

6.74

 

   Transgender

50

7.80

155

2.62

 

Age at diagnosis (years)

    

0.0003

   13–29

83

12.95

539

9.11

 

   30–39

255

39.78

2361

39.90

 

   40–49

229

35.73

2032

34.34

 

   50+

74

11.54

985

16.65

 

Race/ethnicity

    

<0.0001

   White

260

40.56

3646

61.62

 

   African American

252

39.31

963

16.28

 

   Latino

106

16.54

944

15.95

 

   Asian/Pacific Islander/Native American/Other

23

3.59

364

6.15

 

Risk group

    

<0.0001

   Men who have sex with men

135

21.06

4098

69.26

 

   Injection drug user

257

40.09

634

10.71

 

   Men who have sex with men and inject drugs

213

33.23

881

14.89

 

   Heterosexual/Other

36

5.62

304

5.14

 

Insurance status

    

<0.0001

   Public

212

33.07

1205

20.37

 

   Private

7

1.09

2628

44.41

 

   None

408

63.65

1906

32.21

 

   Unknown

14

2.18

178

3.01

 

Initial AIDS diagnosis

    

0.3518

   CD4 count <200 cells/mm3

503

78.47

4735

80.02

 

   Opportunistic illness

138

21.53

1182

19.98

 

CD4 count at diagnosis (mean cells/mm 3 ) †

 

172

 

184

0.0346

Ever received highly active antiretroviral therapy

    

<0.0001

   Yes

454

70.83

4870

82.31

 

   No

187

29.17

1047

17.69

 

Ever received prophylaxis against Pneumocystis jirovecii pneumonia

     

   Yes

417

65.05

3384

57.19

0.0001

   No

224

34.95

2533

42.81

 

Ever received prophylaxis against Mycobacterium avium complex

     

   Yes

173

26.99

1099

18.57

<0.0001

   No

468

73.01

4818

81.43

 
  1. * Chi square test for differences in proportions and t test for differences in means.
  2. † Excludes 205 cases that were missing CD4 results.